Toggle navigation
Home
Search
Services
Blog
Contact
About
Drug Cross Resistance Patterns in Human Cell Lines
Thilagar, Arulasanam K.
Sitek Research Laboratories, Rockville, MD, United States
Search 10 grants from Arulasanam Thilagar
Search grants from Sitek Research Laboratories
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Reconstruction of cardiovascular regulatory networks from large-scale single-cell analyses of cardiovascular lineages
Health Services Career Development: Improving Medical Decisions in Ovarian Cancer
Quantitative electroencephalography after cardiac arrest
Improving T Cell Therapy of Nasopharyngeal Cancer
Control of TGF-beta Activity in Bone
Recently added grants:
Increasing the Selectivity of Hybrid Mass Spectrometry using Multidimensional Ion Mobility Spectrometry
Oklahoma Center for Microbial Pathogenesis and Immunity
Personalized, Responsive Intervention Sequences for Minimally Verbal Children with Autism (PRISM)
Acetylcholine Receptors in Cell Migrationis
Biasing cell-fate specification through identification and perturbation of mechanisms regulating noise in NANOG expression.
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057825-000
Application #
3613441
Study Section
Project Start
1985-09-30
Project End
Budget Start
1985-09-30
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Sitek Research Laboratories
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20850
Related projects
NIH 1986
N43 CM
Drug Cross Resistance Patterns in Human Cell Lines
Thilagar, Arulasanam K. / Sitek Research Laboratories
NIH 1985
N43 CM
Drug Cross Resistance Patterns in Human Cell Lines
Thilagar, Arulasanam K. / Sitek Research Laboratories
Comments
Be the first to comment on Arulasanam Thilagar's grant